Fact CheckerSign in

NCT06890767Active, not recruiting

Remote Monitoring of COPD Patients Experiencing an Acute Exacerbation Through Health Evaluations Using Wearable Mobile Technology

Source: ClinicalTrials.gov · Last updated 18 Sept 2026

Brief summary (registry, in English)

Chronic obstructive pulmonary disease (COPD) causes about 3 million deaths annually and significantly burdens healthcare systems, costing the EU 38.6 billion euros, largely due to frequent hospitalizations triggered by acute exacerbations (AECOPD). AECOPD worsens patient health, accelerates lung decline, and lowers quality of life, highlighting the need for early detection. Moreover, these AECOPD events happen in an out-hospital setting and are therefore, not preventable. A clear clinical and quality-of-life need arises to reduce AECOPD-related events and consequent hospitalizations. Mobile health (mHealth) offers a solution by monitoring patients remotely using unobtrusive wearable devices. Parameters like peripheral oxygen saturation (SpO2) and respiratory rate can detect and predict exacerbations. However, no data at home is available of AECOPD events and robust predictive algorithms are lacking. This study aims to monitor vital parameters at home, tracking physical activity, pulse, respiratory rate, SpO2, sleep, and skin temperature from the moment of ER admission until three months post-discharge. Data will be used to gain insight in the COPD progression following an AECOPD event and to construct a predictive model, enabling timely intervention, reducing hospitalizations, and improving outcomes.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
10 Mar 2025
Start date
1 Mar 2025
Primary completion date
3 Nov 2026
Lead sponsor
David Ruttens
Diseases
COPD
NCT number
NCT06890767

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 1 Mar 2025 to the primary completion date, 3 Nov 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous diagnosis of asthma

Other

  • Not in the possession of a smartphone

Who the study is looking for

  • Provide signed and dated informed consent
  • Adults older than 18 years of age
  • Previously diagnosed with COPD
  • Speak and understand the Dutch language
  • Need for hospitalization

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ziekenhuis Oost-Limburg
Coordinator of this site? Confirm its status
GenkBelgiumUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.